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                                                                ABSTRACT  
Background: 
Serum concentration of certain lipids in young children is an important risk 
factor for the development of coronary heart disease in later life.   Older-
generation AEDs which are commonly used for the treatment of epilepsy 
including phenytoin, carbamazepine, phenobarbitone and valproate exert 
prominent effects on the hepatic enzyme system and may alter metabolic 
pathways that are related to increased vascular risks.  
OBJECTIVE:To assess the effect of commonly used antiepileptic drugs on 
serum lipid levels in epileptic children 
METHODS: The study population were divided into two groups: cases which 
includes children receiving AEDs for more than 6 months and controls as 
healthy children. A blood sample (3 ml)was drawn after an overnight fast and 
serum glucose,liver enzymes,total cholesterol, HDL-C, LDL-
C,Triglycerides,VLDL-C were measured. All data were entered in Microsoft 
excel sheet and was imported to SPSS software. Analysis were performed using 
SPSS, Version 20.0 
RESULTS: Enzyme inducer antiepileptic drugs like Carbamazepine and 
Phenobarbitone increases TC,LDL-C,TGs and lowers HDL-C. Phenytoin 
increases TC,TGs,and lowers HDL-C 
Sodium valproate and Levitiracetam did not have significant changes in the 
serum lipid profile.  
Conclusion: Anticonvulsant drugs especially the enzyme inducers significantly 
modify serum lipids in epileptic children. Newer generation AEDs like 
Levitiracetam is found to be safe to use in children who require long term 
anticonvulsant therapy 
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